Skip to main content

Published locations for TLR9 agonist may overcome resistance to anti–PD-1 therapy in melanoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. TLR9 agonist may overcome resistance to anti–PD-1 therapy in melanoma

User login

  • Reset your password
  • /content/tlr9-agonist-may-overcome-resistance-anti-pd-1-therapy-melanoma
  • /edermatologynews/article/212140/melanoma/tlr9-agonist-may-overcome-resistance-anti-pd-1-therapy
  • /oncologypractice/article/212140/melanoma/tlr9-agonist-may-overcome-resistance-anti-pd-1-therapy
  • /hematology-oncology/article/212140/melanoma/tlr9-agonist-may-overcome-resistance-anti-pd-1-therapy
  • /dermatology/article/212140/melanoma/tlr9-agonist-may-overcome-resistance-anti-pd-1-therapy-melanoma